Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",49435,304,1.09 [0.96-1.24],0.1857772479955319
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",51225,400,1.09 [0.98-1.22],0.1255183840041206
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",50696,2769,1.05 [1.01-1.10],0.016479316941477
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Candidiasis,51262,862,1.07 [1.00-1.16],0.0595286425563886
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,49714,7018,1.05 [1.02-1.08],0.0005549868339208
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),49900,6380,1.04 [1.01-1.07],0.0109936072072818
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,50761,2429,1.05 [1.00-1.10],0.0318587417926491
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,51079,174,1.06 [0.90-1.25],0.4954689160575044
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,47180,1948,1.06 [1.01-1.12],0.0197526821644939
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,45583,2210,1.07 [1.02-1.12],0.0062237310401504
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,45317,517,1.11 [1.01-1.23],0.0305668109370016
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,36008,3950,1.05 [1.01-1.09],0.0055736261081685
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,45012,786,1.13 [1.04-1.22],0.0030749155063141
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,51195,2863,1.05 [1.01-1.09],0.0250291577881611
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Mycoses,51418,1018,1.08 [1.01-1.15],0.0345549105621322
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,49789,1862,1.06 [1.01-1.12],0.0239405364539607
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,51285,2154,1.06 [1.01-1.11],0.0133447050642385
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,48734,402,1.08 [0.97-1.21],0.145471995929771
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,51521,96,1.24 [1.00-1.54],0.0548881656826325
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,51010,1879,1.05 [1.00-1.10],0.0638122158742853
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,51060,155,1.18 [1.00-1.41],0.0552056593911121
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,51358,319,1.22 [1.08-1.38],0.0010094207988312
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",51319,280,1.22 [1.08-1.39],0.0019617853340387
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,48764,837,1.14 [1.06-1.23],0.0007063143310546
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,48484,557,1.00 [0.91-1.10],0.9607560454355578
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,48550,218,1.11 [0.96-1.29],0.1716848813636434
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,51478,107,0.92 [0.74-1.14],0.447066319804309
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,51391,307,1.05 [0.92-1.18],0.4905443620928932
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Viral warts,51186,102,1.17 [0.94-1.45],0.1514529094637718
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],51214,130,1.03 [0.85-1.25],0.7748260444643521
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign lipomatous neoplasm,50929,586,0.97 [0.88-1.06],0.4721435993815739
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,51345,115,1.07 [0.88-1.31],0.4966809066241331
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,51306,125,1.10 [0.90-1.33],0.3451406436894438
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,23680,129,0.92 [0.76-1.13],0.4327690058573707
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",50860,2873,1.02 [0.98-1.06],0.4214216105831179
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm of meninges,51495,114,1.20 [0.98-1.47],0.0744502520640556
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,51389,134,1.08 [0.89-1.31],0.4202301116954691
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,51471,215,1.07 [0.92-1.24],0.372624042633174
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm of ovary,27708,179,1.04 [0.89-1.23],0.6128853280115039
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,51474,720,0.99 [0.91-1.07],0.7783615426380233
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm: Caecum,51475,592,0.99 [0.90-1.09],0.8404309434844552
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",51304,146,0.93 [0.77-1.12],0.446720391013645
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm: Descending colon,51470,437,0.97 [0.87-1.08],0.5806375574602394
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm: Rectum,51392,699,0.97 [0.89-1.06],0.5129160476825778
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,51293,1233,0.99 [0.93-1.06],0.7996039507330631
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,51456,859,1.04 [0.97-1.12],0.2968347798806762
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Carcinoma in situ of breast,22518,139,0.82 [0.68-0.99],0.0420745125030138
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",22609,170,0.95 [0.80-1.13],0.5795935572102504
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",41020,104,1.14 [0.92-1.42],0.2201097639616303
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",41051,135,0.94 [0.77-1.14],0.5269597849211914
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",51420,239,0.91 [0.79-1.05],0.1869694504016044
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Haemangioma, any site",51421,234,0.91 [0.79-1.05],0.2116799652108359
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Leiomyoma of uterus,26791,593,0.96 [0.88-1.05],0.3852797481742012
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Lung cancer and mesothelioma,35708,657,1.03 [0.94-1.12],0.5142919793732652
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Lymphoid leukaemia,41018,102,1.13 [0.91-1.41],0.2510382442698605
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",41295,379,1.01 [0.91-1.14],0.8055222123966251
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",41323,407,0.99 [0.89-1.11],0.8813688371042431
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",22739,185,0.89 [0.76-1.05],0.1832982102796516
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",41078,162,0.98 [0.82-1.16],0.7796564091593368
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",41131,215,1.08 [0.93-1.26],0.2946317742221758
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",41114,198,0.99 [0.85-1.16],0.9109738706159992
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",22696,142,1.02 [0.84-1.23],0.8536346925978541
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",41105,189,1.08 [0.92-1.27],0.3478825774937958
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",19750,1388,0.98 [0.93-1.04],0.5734703854942916
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",41148,232,1.01 [0.87-1.17],0.8923389855437222
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",41065,149,1.23 [1.04-1.47],0.0190703499650671
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,41128,212,0.93 [0.79-1.08],0.3256023641702428
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Melanocytic naevi,51123,400,1.01 [0.91-1.13],0.8105696802712254
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Melanocytic naevi of trunk,51440,176,1.06 [0.90-1.25],0.5057263370475773
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Melanoma in situ,40984,163,1.14 [0.96-1.36],0.130040527310583
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",41097,181,0.97 [0.82-1.15],0.7533303138661491
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",41239,323,1.01 [0.89-1.14],0.9355404216982788
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",41364,448,0.95 [0.85-1.05],0.3237666348681263
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",41115,199,1.04 [0.89-1.22],0.630564066492173
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Other benign neoplasms of skin,51160,310,1.00 [0.88-1.13],0.9986831346587478
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",43071,2155,0.98 [0.94-1.03],0.4798601751630902
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",43187,2271,0.99 [0.94-1.04],0.6763651868917131
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,50934,688,1.01 [0.93-1.10],0.8441278456124736
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,47739,225,1.12 [0.96-1.29],0.1450102283735566
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,50388,142,1.10 [0.92-1.33],0.2930500492807957
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,49935,5802,1.06 [1.03-1.09],0.0001977399755068
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,48569,97,1.23 [0.98-1.53],0.0697460230439772
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,50684,99,1.01 [0.81-1.26],0.9529678605871093
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,50554,3040,1.08 [1.04-1.12],0.0002285618219029
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,50552,3038,1.08 [1.04-1.12],0.0002587644383209
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,47689,175,0.94 [0.80-1.12],0.5024688444278622
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,50861,2389,1.13 [1.08-1.19],3.036672827119532e-08
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,50812,227,0.95 [0.82-1.10],0.4745202754648407
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,50377,131,1.05 [0.87-1.28],0.6084086058935678
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,50365,119,1.07 [0.88-1.31],0.4974607208076652
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,51137,552,0.83 [0.75-0.91],0.0001256804868017
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,51308,111,1.10 [0.90-1.35],0.3532480010891443
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",51040,455,0.75 [0.67-0.83],1.2417549562729678e-07
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,48685,213,1.11 [0.95-1.29],0.1906004518791433
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,39834,642,1.07 [0.98-1.17],0.1404146293109745
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,48048,233,1.07 [0.93-1.24],0.3290989153840502
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,48069,254,1.10 [0.96-1.26],0.1834447305215988
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,39301,109,1.13 [0.92-1.39],0.245902386528586
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,47850,137,0.97 [0.80-1.17],0.7698754387296763
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,46709,471,0.98 [0.88-1.08],0.6572463808857645
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",50572,1128,0.97 [0.91-1.04],0.4231861418965557
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,49975,531,0.94 [0.85-1.04],0.2412421230738154
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,49699,255,1.11 [0.96-1.27],0.1503373578147012
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,50816,3103,1.08 [1.03-1.12],0.0002925998621282
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,44887,3007,1.08 [1.04-1.12],0.0002205371052204
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",39325,133,0.94 [0.78-1.15],0.560158833529211
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",47486,157,1.01 [0.85-1.21],0.8944503168991368
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,39751,559,1.12 [1.02-1.23],0.0155260202465622
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,39315,123,1.18 [0.97-1.43],0.0962842036277402
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,46256,7064,1.08 [1.05-1.11],8.824242114380182e-09
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,39581,389,1.04 [0.93-1.16],0.520087277540678
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,40308,1116,1.08 [1.01-1.16],0.0163294556673652
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,51359,655,1.15 [1.05-1.25],0.0014977171119252
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,50983,279,1.17 [1.02-1.33],0.0211843218459583
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,39450,258,1.03 [0.90-1.18],0.6533964200889781
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",39313,121,1.05 [0.85-1.28],0.6666764222953223
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,50436,3107,1.05 [1.01-1.09],0.0113882582403033
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,39718,526,1.14 [1.03-1.25],0.008203990251124
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,39794,602,1.03 [0.94-1.13],0.5664111583609481
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",40466,1274,1.09 [1.02-1.16],0.0090199608279024
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,39430,238,0.96 [0.83-1.11],0.5438227256367034
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,50966,262,1.15 [1.01-1.32],0.0376663047714214
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,40402,1210,1.06 [0.99-1.13],0.0752211851151851
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,40150,958,1.04 [0.97-1.12],0.2967339146247767
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,46375,137,1.08 [0.90-1.30],0.414841133651879
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,49153,9961,1.07 [1.04-1.09],1.6374913862278413e-08
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,47427,98,1.00 [0.80-1.25],0.9956946322073684
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,47438,109,0.99 [0.80-1.22],0.9320697350830244
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,51146,3891,0.99 [0.95-1.02],0.5085041017561291
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",51148,3886,0.99 [0.95-1.02],0.5380937444265488
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,47433,104,1.21 [0.98-1.50],0.074719328295231
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,50830,2402,1.06 [1.01-1.10],0.0183594926672548
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",42370,3178,1.05 [1.01-1.10],0.0082421334285854
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,51495,459,1.02 [0.92-1.13],0.6752749444513885
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,49610,166,1.02 [0.86-1.22],0.7934981506056585
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,48636,208,0.99 [0.85-1.16],0.9451945524914928
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,48716,288,1.19 [1.05-1.35],0.0074741938545704
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",39524,332,1.21 [1.08-1.36],0.0015192685291701
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,46869,300,1.05 [0.93-1.19],0.4445375291334403
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,4233,173,0.98 [0.83-1.17],0.8369347336821289
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,4508,505,1.00 [0.90-1.10],0.9346940211956972
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,46694,125,1.13 [0.93-1.37],0.2146162198717586
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,4170,113,1.00 [0.81-1.24],0.996762555360378
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,50238,3669,1.08 [1.04-1.12],7.899155291946839e-05
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,50141,697,0.91 [0.83-0.99],0.0260850082122733
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,46967,729,1.05 [0.96-1.13],0.2853207575096925
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,40741,1549,1.08 [1.02-1.15],0.0049615474438075
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",51296,489,0.96 [0.87-1.06],0.4134105062893786
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),49258,328,0.90 [0.79-1.02],0.0915041554084355
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Angina pectoris,47050,2394,1.02 [0.98-1.07],0.3525290501612836
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,49411,481,0.92 [0.83-1.02],0.1051846353445164
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,49051,121,1.22 [1.00-1.48],0.0467092586268353
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",49329,399,1.12 [1.00-1.25],0.0469470821935608
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,31943,3819,1.00 [0.96-1.03],0.8063529322821839
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,AV-block,43386,867,1.03 [0.96-1.11],0.3929271928417218
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",51403,842,0.91 [0.84-0.98],0.0149030326262352
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Cardiac arrest,28507,383,1.20 [1.08-1.34],0.0011315457006011
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,42862,343,0.87 [0.77-0.99],0.0315334862270818
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",42714,195,0.93 [0.80-1.10],0.4069410258560408
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,51517,104,1.02 [0.82-1.28],0.83255671610835
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Conduction disorders,44633,2114,1.02 [0.97-1.07],0.4283797317302967
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,48770,4149,1.04 [1.01-1.08],0.0129178878738482
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,44931,15088,1.04 [1.02-1.06],2.059995609312742e-05
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,48758,528,0.97 [0.88-1.07],0.4980444556350104
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Endocarditis,42667,148,1.09 [0.91-1.30],0.3611639253793637
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",51109,2203,1.07 [1.02-1.12],0.0050202782308503
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Hypertension,46766,12956,1.05 [1.03-1.07],1.401899640092498e-06
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",46802,12992,1.05 [1.03-1.07],1.5208063536413771e-06
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",51179,159,0.88 [0.74-1.05],0.1677381157382572
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",34165,355,1.04 [0.92-1.17],0.5673148565492472
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,34087,277,1.27 [1.11-1.45],0.000329658016259
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Hypotension,51228,2351,1.04 [1.00-1.09],0.072175544694837
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,49677,213,0.95 [0.82-1.11],0.5366528462689123
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",49113,4457,1.04 [1.01-1.08],0.0187695383368346
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",50767,1118,1.07 [1.00-1.14],0.0592924242337097
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,43249,730,1.02 [0.94-1.11],0.5770158836292528
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,50558,1675,1.05 [0.99-1.10],0.0991370491972015
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",46069,1413,1.06 [1.00-1.13],0.0358680532766795
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",51333,310,1.13 [1.00-1.28],0.0549287711277887
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",51460,617,1.02 [0.94-1.12],0.6110308522056933
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Oesophageal varices,48340,110,0.87 [0.70-1.08],0.2156906690454519
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other aneurysm,49087,157,0.98 [0.82-1.17],0.8471713752675515
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,43364,845,1.03 [0.95-1.11],0.5053082471581128
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,49135,205,1.18 [1.02-1.37],0.0309091513094716
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,49412,482,0.97 [0.88-1.07],0.5714720608035632
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,42873,354,0.99 [0.88-1.11],0.8592410780857281
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other disorders of veins,48423,193,1.00 [0.85-1.17],0.989096438675145
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,48326,96,1.20 [0.97-1.50],0.0994439543157076
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,48659,130,0.95 [0.78-1.15],0.5958734564132981
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,48502,272,0.99 [0.87-1.14],0.936918396514296
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,44587,2068,1.00 [0.95-1.05],0.8591574828417167
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,48989,112,0.92 [0.75-1.14],0.4518945446474131
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,50012,1082,1.06 [0.99-1.13],0.0937874242473799
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,50293,693,1.06 [0.98-1.15],0.1699940228895894
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",49749,1220,1.00 [0.94-1.07],0.9669937202024156
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,28801,677,0.95 [0.88-1.04],0.2797213718730308
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,49675,807,1.07 [0.99-1.16],0.0863315096646597
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),48919,689,0.99 [0.91-1.07],0.7495095024283209
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,50546,946,1.05 [0.97-1.12],0.2242310363888892
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,51379,1321,1.01 [0.95-1.08],0.6422849071489607
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,43221,702,1.00 [0.92-1.09],0.9668210937446
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,50282,682,1.06 [0.98-1.16],0.1549158939622587
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,48913,384,1.01 [0.90-1.13],0.8246258645904267
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",50747,1283,1.05 [0.99-1.12],0.1224346865637403
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",50705,1359,1.04 [0.98-1.11],0.1818403954130436
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,49618,117,0.95 [0.77-1.17],0.6225700354808406
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,49090,161,0.87 [0.73-1.04],0.1151487559947304
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,50121,472,1.06 [0.96-1.18],0.2476775387469361
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,49403,520,1.09 [0.99-1.20],0.0922934261977393
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Varicose veins,49076,846,1.00 [0.93-1.08],0.9771354799370834
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,48960,173,0.93 [0.79-1.11],0.4228723134018325
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,51068,1499,1.01 [0.96-1.07],0.6618901274756285
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",51277,718,1.05 [0.97-1.14],0.2051690199651608
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",45076,2841,1.07 [1.02-1.11],0.002118489070513
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Any mental disorder,50213,7978,1.04 [1.02-1.07],0.0011382264063736
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",51187,850,1.05 [0.97-1.13],0.2258693104441847
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",45393,3158,1.07 [1.03-1.12],0.0003179497994043
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",42417,182,1.02 [0.87-1.21],0.787028989003268
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Smoking dependency,50454,2730,1.03 [0.99-1.07],0.1890936674480547
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",45489,3254,1.04 [1.00-1.08],0.0582145473351092
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Vascular dementia,50504,253,0.88 [0.77-1.02],0.0946028216534918
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Alzheimer disease,51520,659,0.98 [0.90-1.07],0.6861719607603152
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",34735,116,0.99 [0.80-1.22],0.89376134002731
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Bell's palsy,47959,163,1.04 [0.88-1.24],0.6493140612704151
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,48774,978,1.03 [0.96-1.11],0.3766247247416885
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Cerebral cysts,50711,462,1.05 [0.95-1.17],0.3156206653387178
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,51358,644,0.98 [0.90-1.07],0.6698905311877784
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,50517,99,1.06 [0.85-1.32],0.6081994668396551
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,51486,122,1.01 [0.83-1.24],0.9129699274672004
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",50397,148,0.99 [0.82-1.18],0.8911911147880835
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Epilepsy,48391,571,0.99 [0.90-1.08],0.7659717237462225
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,50556,2736,1.03 [0.99-1.07],0.1962385031274027
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,51438,1203,1.00 [0.93-1.06],0.9269040806823732
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,50325,5139,0.99 [0.95-1.02],0.341754669666272
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Generalized epilepsy,50757,108,1.13 [0.92-1.39],0.2531761557170014
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Hemiplegia,51217,503,1.02 [0.92-1.12],0.7422004164264485
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Hydrocephalus,50368,119,1.11 [0.91-1.36],0.299221298193312
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,51483,138,1.26 [1.05-1.51],0.0125830311441357
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,47942,146,0.92 [0.77-1.11],0.4033803723005983
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,47954,158,1.08 [0.91-1.28],0.3935731220516149
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Memory loss,50214,214,0.91 [0.78-1.06],0.2412917547386786
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Migraine,48536,716,1.04 [0.96-1.13],0.3478903932584583
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",51379,644,1.04 [0.95-1.13],0.4263597518697403
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Motor neuron disease,34927,269,1.07 [0.93-1.22],0.3393160858811999
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,51186,205,0.98 [0.84-1.15],0.8445561526356409
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",50185,2389,1.05 [1.00-1.10],0.0410203642522263
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Neurological diseases,48569,7519,1.02 [1.00-1.05],0.1080362552576415
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,50822,404,0.99 [0.89-1.11],0.9136675744813738
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",48623,827,1.09 [1.01-1.18],0.0199310809558987
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",51366,597,1.06 [0.97-1.16],0.2016752457158945
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,40984,1293,1.01 [0.95-1.07],0.8658288150936314
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,50394,145,0.99 [0.82-1.19],0.9061901642309028
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,50527,278,0.90 [0.78-1.02],0.1079250370051082
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,50563,328,1.05 [0.93-1.19],0.4103190450107145
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,47988,192,1.03 [0.88-1.21],0.700587705637487
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other headache syndromes,47935,115,1.08 [0.88-1.33],0.451501077531289
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other neurological diseases,51281,1032,1.03 [0.96-1.10],0.4065302028547383
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other sleep disorders,48935,1115,1.03 [0.96-1.10],0.4598936558449757
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Parkinson's disease,51476,849,0.97 [0.89-1.04],0.3728402608588719
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,50361,112,1.14 [0.93-1.40],0.2032646498286996
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Restless leg syndrome,51519,154,1.09 [0.91-1.30],0.3655234299389792
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Sleep apnoea,51032,958,1.03 [0.96-1.10],0.4749761775599662
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,50869,100,1.14 [0.92-1.42],0.233554118669304
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,51493,323,1.04 [0.92-1.18],0.5014518659687504
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,47897,101,0.99 [0.79-1.23],0.9180315375063284
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,51520,666,0.98 [0.90-1.07],0.7227543322726058
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),50429,246,0.89 [0.77-1.03],0.1066519820603424
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,50378,198,1.03 [0.88-1.20],0.7287702371195683
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,50699,783,0.99 [0.91-1.07],0.7553315882856709
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,51169,463,0.99 [0.89-1.10],0.8266871363042172
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,49520,105,1.04 [0.83-1.29],0.7526002547855104
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,49529,114,1.17 [0.96-1.43],0.1185719869916181
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",51306,103,1.21 [0.97-1.49],0.0860383618786942
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,50997,287,1.03 [0.91-1.18],0.6194311497318913
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",4181,121,1.05 [0.86-1.29],0.6293543938217765
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,5066,204,1.00 [0.86-1.17],0.99196641351229
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,50363,183,1.13 [0.96-1.32],0.1439258723626852
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,51082,2062,1.01 [0.97-1.06],0.5747192849964742
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",50795,1380,0.99 [0.93-1.05],0.6747006271995326
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,49860,445,1.04 [0.93-1.15],0.5019756117140393
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",51349,1433,1.01 [0.95-1.07],0.826155842753854
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,51501,136,1.07 [0.89-1.30],0.4576381374753144
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,51201,1285,1.00 [0.94-1.06],0.973308173120576
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",51435,725,1.02 [0.94-1.10],0.6862908248610479
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,51334,360,1.05 [0.94-1.18],0.3704188519957928
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,49533,118,1.05 [0.85-1.29],0.6594443807968349
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,49551,136,1.01 [0.83-1.22],0.9168987293862568
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,49524,109,0.96 [0.77-1.19],0.6852129596394333
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,51329,1401,1.02 [0.96-1.08],0.6200570532310441
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,50295,367,1.00 [0.89-1.12],0.9771213378754257
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,50013,97,0.94 [0.75-1.18],0.5735836297524093
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,50909,199,1.00 [0.85-1.17],0.977406076599712
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,51250,540,1.01 [0.92-1.11],0.8818218856093738
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,50301,385,1.02 [0.91-1.14],0.7776433909225635
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,51195,221,1.02 [0.88-1.18],0.8170501319941134
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,50861,933,1.05 [0.98-1.13],0.1789144960940491
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,50463,283,1.02 [0.90-1.17],0.7203359579643446
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,48342,4337,1.04 [1.01-1.08],0.0150615066314251
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,51180,470,1.00 [0.90-1.11],0.971921586580996
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,51479,307,1.07 [0.94-1.21],0.3043167314594855
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,50233,818,0.98 [0.90-1.06],0.5617864981628464
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,50839,129,0.95 [0.78-1.16],0.6466597345527251
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,51475,110,1.08 [0.88-1.33],0.4555485410627631
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,49584,169,0.89 [0.75-1.06],0.2009931838175847
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,49711,296,0.92 [0.80-1.04],0.1842459344021395
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,49259,239,1.03 [0.89-1.19],0.7044437191884378
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,50040,124,1.03 [0.84-1.25],0.7977147145999697
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",49145,125,0.80 [0.66-0.99],0.0362692761622876
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,50100,172,0.96 [0.81-1.14],0.6333791602108619
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",50319,391,1.07 [0.95-1.19],0.26490212248502
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,49669,254,1.04 [0.90-1.19],0.6161412424529743
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,49242,222,1.18 [1.02-1.36],0.0224384214462831
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,49192,172,1.01 [0.85-1.20],0.8944081482947194
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,47604,3599,1.01 [0.98-1.05],0.4915405723610848
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,49556,141,0.97 [0.81-1.17],0.7631364226698167
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,51002,822,1.06 [0.98-1.14],0.1526579255520296
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,50298,118,1.01 [0.82-1.24],0.9182424408973268
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),50522,342,1.08 [0.96-1.22],0.1928265515339933
PPP1R2,Protein phosphatase inhibitor 2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,51109,174,0.91 [0.77-1.08],0.2683724767861481
PPP1R2,Protein phosphatase inhibitor 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,51431,237,1.00 [0.87-1.16],0.980693318156572
PPP1R2,Protein phosphatase inhibitor 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,51256,255,1.08 [0.94-1.24],0.2617377266449778
PPP1R2,Protein phosphatase inhibitor 2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,51055,120,1.03 [0.84-1.26],0.7750297684870165
PPP1R2,Protein phosphatase inhibitor 2,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,51057,122,0.99 [0.81-1.21],0.9008556357311188
PPP1R2,Protein phosphatase inhibitor 2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,51322,1798,1.02 [0.97-1.08],0.4451056251458306
PPP1R2,Protein phosphatase inhibitor 2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,50813,1289,1.04 [0.98-1.11],0.1702272924229881
PPP1R2,Protein phosphatase inhibitor 2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,49775,251,0.85 [0.74-0.99],0.0310298700139246
PPP1R2,Protein phosphatase inhibitor 2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,49694,170,1.13 [0.96-1.33],0.152408719111554
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Acute pharyngitis,51031,148,0.86 [0.72-1.04],0.1155063936081205
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,51310,427,0.90 [0.81-1.00],0.0515134396823974
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,51012,129,0.90 [0.74-1.10],0.3037614132477426
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,All influenza,47492,239,1.06 [0.92-1.23],0.4005470780068401
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),47487,234,1.08 [0.94-1.25],0.2719747799090679
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),35281,230,1.11 [0.96-1.28],0.1434513457599986
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Allergic rhinitis,51257,559,1.09 [0.99-1.19],0.0714378718079684
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",38040,3524,1.07 [1.03-1.11],0.0003273931079018
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",38525,3474,1.07 [1.03-1.11],0.0002573821011752
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),50709,278,1.16 [1.02-1.32],0.0231558587748826
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",47416,163,1.20 [1.01-1.42],0.0349622995812627
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Bronchiectasis,44644,707,1.19 [1.09-1.29],4.593095604898484e-05
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",44055,118,1.30 [1.07-1.58],0.0096668258707078
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,49491,5554,1.06 [1.03-1.10],4.035900112347083e-05
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",48787,142,1.04 [0.86-1.25],0.6998012092734848
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,48952,307,1.14 [1.01-1.29],0.033261969326758
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",51124,2369,1.05 [1.00-1.09],0.0527963049611049
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,48853,208,1.08 [0.93-1.25],0.3358104339330642
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,47391,10489,1.05 [1.03-1.08],1.2722297228181522e-06
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",49368,723,1.06 [0.98-1.15],0.1455022728689278
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Early onset COPD,49377,622,1.03 [0.94-1.12],0.5784316091210845
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Emphysema,44569,632,1.16 [1.06-1.26],0.0009101250015656
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,48940,574,1.09 [0.99-1.19],0.0792798937977658
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,51080,3827,1.05 [1.02-1.09],0.0049856062991256
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,49011,645,1.10 [1.01-1.20],0.0326172480963984
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Later onset COPD,49532,1747,1.06 [1.00-1.12],0.0369878686865125
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,51496,658,1.07 [0.98-1.17],0.1113515499743453
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Nasal polyp,48855,210,1.07 [0.92-1.24],0.3909198626364577
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,51019,1937,1.09 [1.03-1.14],0.0011235119266059
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,51046,3977,1.07 [1.03-1.10],0.000387356765985
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,50307,1662,1.08 [1.03-1.14],0.0041088990833201
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other pleural conditions,47172,103,1.00 [0.80-1.24],0.997356295447258
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,51344,804,1.09 [1.01-1.18],0.0302209697284209
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,51309,2595,1.09 [1.05-1.14],4.735668120905938e-05
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Pleural effusion,49053,1984,1.06 [1.01-1.12],0.0142667289229433
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Pleural plaque,47378,309,1.03 [0.91-1.17],0.6623652729420146
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",50577,3324,1.05 [1.01-1.09],0.0123794633807059
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,51366,528,1.07 [0.97-1.18],0.162027471405514
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Pneumothorax,47304,235,0.99 [0.85-1.14],0.8531787855043643
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Pollen allergy,51474,478,1.10 [0.99-1.21],0.0721884538311359
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Pulmonary oedema,50674,134,1.05 [0.87-1.27],0.6191069346635716
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,35159,108,1.22 [0.99-1.50],0.0621578717780637
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,50976,1894,1.08 [1.03-1.14],0.0017776216014729
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,49206,561,1.09 [1.00-1.20],0.0579286263922814
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Viral pneumonia,47753,500,1.03 [0.94-1.14],0.5068605992487273
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",50737,411,0.99 [0.88-1.10],0.8080484408650601
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,23743,226,1.06 [0.91-1.23],0.4400682159653627
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,36381,128,1.05 [0.86-1.27],0.6504921314428747
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Acute appendicitis,51202,284,0.97 [0.85-1.10],0.631181587890516
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Acute gastritis,38730,181,1.03 [0.88-1.22],0.6929714059548608
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,47828,366,1.08 [0.97-1.22],0.165069297191509
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Acute peritonitis,50581,187,1.15 [0.98-1.35],0.0887181730437112
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,49731,150,0.93 [0.78-1.12],0.4435221827300469
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Barrett oesophagus,39420,871,1.00 [0.92-1.07],0.9244648737120192
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",47667,205,1.11 [0.95-1.29],0.1808527897008768
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",50679,205,1.11 [0.95-1.29],0.2011682959428802
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Cholecystitis,47871,409,0.99 [0.89-1.11],0.9035903694929968
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Cholelithiasis,49443,1981,1.05 [1.00-1.10],0.0668935535658871
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Chronic gastritis,39166,617,1.05 [0.96-1.15],0.269215275633171
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,47558,96,1.09 [0.87-1.36],0.448780762446492
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",51232,212,0.95 [0.81-1.10],0.483186578240408
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Coeliac disease,48314,248,1.10 [0.96-1.26],0.1823359026561071
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Collagenous colitis,48163,162,1.04 [0.87-1.23],0.6771192268868165
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,51213,375,0.97 [0.87-1.09],0.6251625466502324
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Constipation,51001,3355,1.01 [0.97-1.05],0.5408456627945923
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Crohn disease,48185,184,1.10 [0.94-1.30],0.2289559057983317
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",50810,135,1.11 [0.92-1.34],0.266638782699912
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,48175,174,1.13 [0.96-1.33],0.1473200975057393
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Dental caries,50040,453,1.11 [1.00-1.23],0.0429100857582006
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,46226,4447,1.02 [0.99-1.05],0.2681098612292806
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of appendix,51275,357,0.99 [0.88-1.11],0.8963738882773853
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of liver,51279,1698,1.03 [0.97-1.08],0.3630993872630723
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",47177,8628,1.01 [0.99-1.04],0.2581436037292253
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",50691,1104,1.07 [1.00-1.14],0.05417548700946
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,51352,958,1.09 [1.01-1.17],0.0203350414405776
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,49816,229,1.00 [0.87-1.16],0.9488871296227432
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,49520,133,1.07 [0.88-1.29],0.4956599736011318
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,50888,2822,1.03 [0.99-1.07],0.1949815528491264
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of tongue,49552,218,1.01 [0.87-1.18],0.8577089021841673
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",50268,2806,1.05 [1.01-1.09],0.0262187123532601
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,42548,6295,1.02 [0.99-1.05],0.1345126735755807
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,38946,397,1.03 [0.92-1.15],0.6596299012425851
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",51354,321,1.02 [0.90-1.15],0.7759702984425024
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,51342,111,1.29 [1.06-1.58],0.0121430608307362
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,49838,257,0.97 [0.84-1.11],0.6245738386171047
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,36547,294,0.99 [0.87-1.13],0.9233724958580728
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,39641,1092,1.01 [0.95-1.08],0.7507854470833966
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Gastric ulcer,39273,724,1.05 [0.97-1.14],0.2024709984384439
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,43551,5002,1.03 [0.99-1.06],0.1028787886015591
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,39627,1078,1.04 [0.97-1.11],0.2970712054725053
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,39867,16520,1.02 [1.00-1.03],0.0735395083679056
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,GI-bleeding,50375,2309,1.01 [0.96-1.05],0.7880406818909148
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,49693,106,1.12 [0.91-1.38],0.2922849201307264
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,38195,2504,1.02 [0.98-1.07],0.357992475881667
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",49706,125,0.98 [0.80-1.19],0.8183626279543994
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Hernia,48263,6484,1.01 [0.98-1.04],0.4767326402590072
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Impacted teeth,51355,103,1.42 [1.16-1.75],0.0007678056425832
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Impaction of intestines,36366,113,1.01 [0.82-1.24],0.940839756538242
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Inguinal hernia,43580,1801,1.00 [0.95-1.05],0.93272042701495
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",41983,204,0.95 [0.81-1.11],0.5135070890408531
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,36445,192,1.01 [0.86-1.19],0.876964024292933
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,48354,288,1.12 [0.98-1.27],0.0938918544859095
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,37353,1100,1.03 [0.96-1.10],0.4096134019083455
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,51461,742,1.12 [1.03-1.21],0.0076881904481079
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,49510,1509,1.09 [1.03-1.15],0.0034863846487986
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,50004,2003,1.08 [1.03-1.13],0.0023679884420115
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,38922,373,1.01 [0.90-1.13],0.8688023169041247
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Oesophagitis,39754,1205,1.04 [0.98-1.11],0.2227259624893036
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,51419,270,1.06 [0.93-1.21],0.3905956615185488
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,41920,141,1.07 [0.89-1.29],0.4699739958743612
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,38959,2706,1.01 [0.97-1.06],0.5895928601930365
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,48031,569,1.05 [0.95-1.15],0.3390322900665377
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,47773,311,0.99 [0.87-1.12],0.8904528815281164
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,39735,3482,0.99 [0.96-1.03],0.6826074510414049
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,47506,11253,1.01 [0.99-1.03],0.5258657669478817
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,49504,412,1.07 [0.96-1.19],0.2491049781517663
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of liver,50976,1395,1.01 [0.95-1.07],0.7246145333103708
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,39877,1328,1.00 [0.94-1.07],0.9386869789869337
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,47765,303,0.99 [0.87-1.13],0.8914632786808069
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,51215,821,1.08 [1.00-1.16],0.0602192559375258
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,40462,1913,0.99 [0.94-1.04],0.7360933869845527
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,50406,2340,1.01 [0.96-1.06],0.7170682629333283
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,49959,372,1.09 [0.97-1.22],0.1286378752525606
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,39703,3450,1.01 [0.97-1.05],0.5453766466224577
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),42560,4011,1.00 [0.96-1.03],0.9046032332302488
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,49781,200,0.95 [0.81-1.11],0.5347474028073782
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,49759,1758,1.06 [1.01-1.12],0.0193538060340972
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",36940,687,0.98 [0.90-1.07],0.622616627895171
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,51322,130,1.29 [1.07-1.55],0.0077778934814659
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,37230,977,0.97 [0.90-1.04],0.4084696717495893
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",48363,297,1.10 [0.97-1.24],0.1534671543500991
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,51498,115,0.91 [0.74-1.12],0.3843511886308384
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,49598,238,1.02 [0.89-1.18],0.7478089738550897
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Toxic colitis,48115,114,0.86 [0.70-1.07],0.1723490840457668
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,39085,536,1.09 [0.99-1.20],0.071160014545028
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,48325,324,1.17 [1.04-1.32],0.0110573832207693
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",48269,268,1.11 [0.97-1.27],0.1244886405264857
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Umbilical hernia,42325,546,0.93 [0.85-1.03],0.1550389584764748
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,36606,353,0.98 [0.87-1.11],0.7671533089688904
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Ventral hernia,42305,526,1.04 [0.94-1.14],0.4381948414068333
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Volvulus,36411,158,0.86 [0.72-1.03],0.0944995036821784
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,51353,586,1.06 [0.96-1.16],0.2345995881734121
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,50874,147,1.04 [0.87-1.25],0.6464157659961409
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,47427,316,1.00 [0.88-1.13],0.9638808755709836
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,50241,1390,1.02 [0.96-1.08],0.5307220644343276
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",49198,347,1.10 [0.98-1.23],0.1216875350718515
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,47925,814,1.01 [0.93-1.09],0.8921258102125118
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,50907,556,1.11 [1.01-1.21],0.0319197683160242
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,51316,965,1.08 [1.01-1.16],0.0330865184158361
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,50447,96,1.16 [0.93-1.45],0.182506913070369
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,48400,6388,1.01 [0.98-1.04],0.3734367705299597
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,50614,894,0.95 [0.89-1.03],0.2195644343233437
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,50348,628,0.98 [0.89-1.07],0.5905948029449153
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,50735,1884,1.02 [0.97-1.07],0.5076549201953281
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",51486,111,1.11 [0.90-1.36],0.3421766292564282
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,47224,113,0.91 [0.74-1.13],0.3983347088326252
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,49825,105,0.99 [0.80-1.23],0.93013199589652
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,50887,536,1.09 [1.00-1.20],0.0595386362387187
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,48018,907,1.02 [0.95-1.10],0.5432947431334942
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,47239,128,0.98 [0.80-1.19],0.8074200384875602
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,51347,164,0.96 [0.80-1.14],0.6095080829913573
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,49234,383,1.14 [1.02-1.27],0.0246301767437176
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,51112,385,0.94 [0.84-1.05],0.2634110539054627
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,50478,127,1.03 [0.85-1.26],0.7685819719396997
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,47244,133,0.95 [0.79-1.16],0.6260363844773884
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,50365,3254,1.01 [0.97-1.05],0.5484912848715647
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",48093,982,1.03 [0.96-1.10],0.4539145456189372
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,47247,136,0.97 [0.81-1.18],0.7925972883983753
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,51339,612,0.99 [0.91-1.09],0.8921231023911171
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,50490,139,1.02 [0.84-1.23],0.8744534528538599
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,51226,499,0.97 [0.88-1.08],0.6040714395032246
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,51409,642,1.03 [0.95-1.13],0.4624644493660208
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,47360,249,1.01 [0.88-1.16],0.8638481120589825
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,47648,537,0.93 [0.85-1.02],0.1449140069888192
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,51387,620,1.04 [0.95-1.13],0.4421623367007785
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",47581,470,1.08 [0.97-1.20],0.1457499359689429
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,51459,276,0.98 [0.86-1.12],0.7532963358556768
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,44201,217,1.06 [0.91-1.22],0.4764432591556455
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,46891,11252,1.03 [1.01-1.05],0.0104377269719377
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,44062,8423,1.03 [1.01-1.06],0.0113993451156684
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,44133,149,0.94 [0.78-1.13],0.4960902780679107
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,44649,303,1.03 [0.91-1.17],0.597276488222126
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,44706,360,1.10 [0.98-1.23],0.1176688608304682
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,51026,183,0.90 [0.77-1.06],0.2249701965049269
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",44545,199,0.96 [0.82-1.13],0.6510544734049677
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,37892,2253,1.03 [0.99-1.08],0.1620467266603235
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",51249,373,1.06 [0.95-1.19],0.3138704678509419
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,45233,887,1.04 [0.97-1.12],0.2775770734302797
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,43546,14484,1.02 [1.00-1.04],0.0151847456575711
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,47583,234,0.94 [0.81-1.09],0.4243214149446251
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,44283,299,0.94 [0.83-1.07],0.3735696970533023
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,45120,1136,1.03 [0.96-1.10],0.3905993322417659
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,49668,5322,1.03 [1.00-1.06],0.0879603043831468
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,44528,544,0.96 [0.87-1.05],0.3460457208879297
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,44427,443,1.21 [1.09-1.34],0.0002183535851641
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,44257,273,1.13 [0.99-1.28],0.0766147284320083
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,50236,140,1.01 [0.84-1.22],0.8954828757598944
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,39021,3382,1.04 [1.00-1.08],0.0675789500077619
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,36847,1208,1.13 [1.06-1.20],0.0002159019076888
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",51365,1191,1.12 [1.05-1.19],0.0006104763509349
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,35786,147,1.17 [0.97-1.39],0.0931216506806353
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),36297,658,0.97 [0.89-1.06],0.5142817519266026
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,44587,603,0.98 [0.90-1.07],0.6706440410021761
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,36918,1279,1.01 [0.95-1.08],0.6725665054538406
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,44457,111,1.22 [0.99-1.49],0.063168033644309
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,45605,1259,1.08 [1.01-1.15],0.017270519204122
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,44954,608,1.09 [1.00-1.19],0.0537926337325721
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,36834,1195,1.00 [0.94-1.07],0.9666823812987206
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,44143,159,1.16 [0.98-1.38],0.0847982615083987
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",44107,123,1.08 [0.88-1.31],0.4632409266694595
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,47493,144,1.05 [0.88-1.26],0.5858888779949102
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,50746,3397,1.00 [0.96-1.04],0.8836397738839933
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,49569,2220,1.00 [0.95-1.05],0.9506304465754528
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",51240,896,1.10 [1.02-1.18],0.0114352244221456
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,40594,4955,1.04 [1.01-1.08],0.0086695867154745
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,35766,127,0.90 [0.74-1.10],0.3009795918472162
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,44173,189,1.23 [1.05-1.44],0.0088627503950362
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,35738,99,0.97 [0.77-1.22],0.7981558964481179
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),35892,253,1.02 [0.88-1.17],0.8187793728687462
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,47824,475,0.94 [0.85-1.05],0.2721297304636845
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,48110,761,1.02 [0.94-1.10],0.7093291179045085
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,51453,197,1.05 [0.90-1.23],0.5113835028796838
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",47961,3615,1.05 [1.01-1.09],0.0132720803006214
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,44184,200,1.01 [0.87-1.18],0.8620092436201806
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),35911,272,0.95 [0.83-1.09],0.4925527462556635
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,45802,1456,1.06 [1.00-1.13],0.0340272969129146
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,39933,4294,1.02 [0.99-1.06],0.154523929128914
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,50287,191,1.03 [0.87-1.21],0.7443847796120772
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,51482,140,1.09 [0.91-1.32],0.3389974223810568
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,44147,163,1.08 [0.91-1.29],0.3608365692635897
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",46476,2492,1.06 [1.02-1.11],0.0060633015503129
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,44160,176,1.00 [0.84-1.18],0.9798281752635496
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,38885,3246,1.05 [1.01-1.09],0.0243774337068747
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,47569,220,0.95 [0.82-1.11],0.5220552741601476
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,44092,108,1.10 [0.89-1.36],0.3662358308075125
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,44659,313,0.93 [0.82-1.05],0.2386877423591676
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,45089,1105,1.01 [0.95-1.08],0.7152534761181262
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,50806,710,1.13 [1.04-1.23],0.0029326849326165
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,45492,1146,1.04 [0.98-1.11],0.1964986244205487
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,51263,869,1.11 [1.03-1.19],0.0062644992709844
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,51476,108,1.18 [0.96-1.45],0.1262840325676949
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,44361,377,0.93 [0.83-1.04],0.1889360948002936
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,40760,1505,1.06 [1.00-1.12],0.042369188829216
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,45143,1159,1.05 [0.98-1.12],0.1612182456051878
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],44438,454,0.95 [0.86-1.06],0.3463834743712385
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",35746,107,0.98 [0.79-1.22],0.886651253074092
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,40606,4967,1.06 [1.03-1.09],0.0002720993815767
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,36954,1315,1.02 [0.95-1.08],0.63181665124989
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,50563,467,1.12 [1.01-1.24],0.0289560647677636
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",51387,131,0.96 [0.79-1.16],0.6477615786641463
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",47186,101,1.09 [0.87-1.36],0.4559634637464729
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,35782,143,1.08 [0.90-1.30],0.3876514310362623
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,44545,199,1.06 [0.91-1.24],0.4377722788364919
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,36547,908,1.10 [1.02-1.18],0.0091778354796622
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,44596,612,0.99 [0.90-1.08],0.7507558855612559
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,44852,506,1.17 [1.06-1.29],0.0016009459160394
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,44721,375,1.05 [0.94-1.18],0.3948308752774425
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,40266,116,1.25 [1.02-1.52],0.0310155099896472
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",51484,116,1.10 [0.90-1.35],0.3372321750442946
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,45154,1170,1.01 [0.95-1.08],0.7990890995202438
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],50279,183,1.12 [0.96-1.32],0.1562930859090179
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,49111,5127,1.03 [1.00-1.07],0.0376216502203964
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",44245,261,1.00 [0.87-1.15],0.9833568427315256
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,45440,1094,1.06 [0.99-1.13],0.0848401094587217
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,48715,464,0.92 [0.83-1.02],0.1143251826391592
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,44759,413,1.01 [0.90-1.12],0.8842998468598089
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,47457,3111,1.02 [0.98-1.06],0.3769665907058769
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,46389,2043,1.03 [0.98-1.08],0.2969610751897274
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],44095,111,1.20 [0.98-1.47],0.0838391542784884
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,50365,269,1.05 [0.92-1.20],0.4877358028595644
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,44306,322,1.06 [0.94-1.20],0.3466990248008516
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,44135,151,0.89 [0.74-1.07],0.1998124739686675
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),35755,116,1.09 [0.89-1.34],0.3892280240247743
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,49413,3141,1.06 [1.02-1.11],0.0021694872296951
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20801,102,1.09 [0.88-1.35],0.448928506517075
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,27078,109,0.90 [0.72-1.11],0.3235151609925511
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,50882,644,1.08 [0.99-1.17],0.0864714303966244
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,50403,165,0.87 [0.73-1.03],0.1120177927564088
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,49334,3062,1.05 [1.00-1.09],0.0288988341008013
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,51093,165,1.09 [0.92-1.30],0.3195508006902224
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,51020,600,1.02 [0.93-1.11],0.6964084089822561
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Cystitis,45382,468,1.06 [0.95-1.17],0.2965840598211062
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Dialysis,46434,162,1.35 [1.14-1.59],0.0004493100595614
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,22456,3298,1.01 [0.97-1.05],0.6421632558442603
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,27310,341,0.98 [0.87-1.11],0.7895556524336822
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Endometriosis,20882,183,1.01 [0.86-1.19],0.8900228446690437
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",21097,398,0.88 [0.79-0.99],0.0315819742541817
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21708,1009,1.01 [0.94-1.08],0.8275180157117245
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,42983,10687,1.00 [0.98-1.03],0.7105295127609057
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,51095,167,1.13 [0.96-1.34],0.1502693064887738
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Hydrocele,19364,206,0.89 [0.76-1.04],0.1577570335385954
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,46253,584,1.05 [0.96-1.15],0.329854166319493
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,21744,2586,1.01 [0.97-1.06],0.6181429864831722
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,27227,405,1.00 [0.89-1.11],0.9426734299695056
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),19393,235,0.96 [0.83-1.12],0.6236382796942244
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Irregular menses,27317,130,0.75 [0.62-0.92],0.0052801047632232
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,21003,304,0.99 [0.87-1.13],0.8893251718922868
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,45074,160,0.99 [0.83-1.18],0.9265228828334824
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,23179,2480,0.98 [0.94-1.03],0.4244871237243293
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,19266,108,0.88 [0.71-1.09],0.2503034443726502
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,20845,146,1.09 [0.91-1.31],0.3531600827859018
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",51494,129,1.09 [0.90-1.32],0.3961630444031846
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",51502,133,0.89 [0.73-1.08],0.2378219004718508
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,49425,4511,1.01 [0.97-1.04],0.6476444313244005
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,46345,1431,0.98 [0.93-1.04],0.5448190264869652
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,27089,120,1.02 [0.83-1.25],0.851290715727046
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,51377,957,1.05 [0.98-1.13],0.2034154435047704
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,19465,307,0.97 [0.86-1.10],0.6511421822629251
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,19443,285,1.04 [0.92-1.19],0.5249056350222701
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,19390,232,0.93 [0.80-1.08],0.3245067680451021
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,51440,141,1.04 [0.87-1.26],0.6627199640426014
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,48388,3474,1.02 [0.98-1.06],0.333940878518031
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,27032,210,1.06 [0.91-1.23],0.4875134925838084
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,20854,155,1.24 [1.04-1.48],0.014358291373295
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",21071,372,0.95 [0.84-1.06],0.3562483384107399
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20814,115,1.08 [0.88-1.32],0.4713097724703536
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,20909,210,1.04 [0.90-1.22],0.573095379993215
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,46346,677,1.04 [0.96-1.13],0.3682089951689756
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,50739,319,1.08 [0.95-1.22],0.2341404143663852
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,21013,314,1.06 [0.93-1.19],0.3948484536114319
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,20807,108,0.93 [0.75-1.16],0.5275494130913632
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21355,656,0.99 [0.90-1.08],0.7602745844538343
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,20863,164,1.13 [0.96-1.34],0.1491664853258992
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21299,600,1.03 [0.94-1.13],0.5045285092404994
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,51024,96,1.01 [0.81-1.26],0.9394861051366424
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",19421,263,1.04 [0.91-1.19],0.5513467426970986
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,51012,5343,1.05 [1.01-1.08],0.004058196870274
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",45906,237,1.09 [0.95-1.26],0.213599837296716
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,46538,266,0.97 [0.84-1.11],0.6228212198816621
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,50346,108,1.03 [0.83-1.27],0.7857766573765361
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,45358,444,1.03 [0.93-1.15],0.5532700788962721
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,51029,791,1.03 [0.95-1.11],0.4719017683680712
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,20843,144,1.12 [0.93-1.34],0.2200406888768213
